Seres Therapeutics Stock Price. Everything You Need To Know About The Seres Therapeutics Stock!
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. The company is headquartered in Cambridge, Massachusetts and currently employs 431 full-time employees. The company went IPO on 2015-06-26. The firm is developing a class of biological drugs, which are designed to treat disease by modulating the microbiome to restore health by repairing the function of a disrupted microbiome to a non-disease state. Its lead product candidate, SER-109, is designed to reduce further recurrence of CDI, a debilitating infection of the colon, in patients who have received antibiotic therapy for recurrent CDI by restructuring the gastrointestinal microbiome and modulating the metabolic landscape to address CDI. Building upon SER-109, it is developing microbiome therapeutics, such as SER-155, to specifically target infections and antimicrobial resistance. SER-155, a microbiome therapeutic candidate consisting of a consortium of cultivated bacteria, is designed to reduce incidences of gastrointestinal infections, bloodstream infections and GvHD in patients receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Seres Therapeutics Stock Price. Everything You Need To Know About The Seres Therapeutics Stock! performance
- Employees 431
- Company HQ Cambridge
- Website https://www.serestherapeutics.com/
- MCRB Asset Type Common Stock
- MCRB Market Capitalization 138.9M
- Earnings Per Share -0.89
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Interested in investing in Seres Therapeutics from Malaysia, Thailand, Indonesia, or Vietnam? Look no further! Zorion, the leading investment platform, offers retail investors in these countries a unique opportunity to invest in real US stocks and Pre-IPO companies like Seres Therapeutics. As a content marketing expert, we are here to guide you on how to invest in this promising stock. With our investment insights and recommendations, you can make well-informed decisions about Seres Therapeutics. Moreover, Zorion provides access to educational resources and materials to enhance your investment knowledge. Don’t miss out on your chance to invest in Seres Therapeutics and join the exciting world of stock investments!
